Exagen(US:XGN)2026-01-12 14:03Financial Results - Exagen Inc. announced preliminary unaudited financial results for Q4 and the year ended December 31, 2025[4]. - The financial closing procedures are not yet complete, and final results may vary from preliminary figures[5]. - The press release includes a cautionary note regarding the select preliminary unaudited financial results[6]. - The company has not provided specific revenue or earnings figures in the current report[4]. - BDO USA, P.C. has not audited or reviewed the preliminary financial information[5]. Regulatory Compliance - The report is filed under the Securities Exchange Act of 1934, indicating compliance with regulatory requirements[9]. - The press release is available as Exhibit 99.1, dated January 11, 2026[7]. Company Information - The company is based in Vista, California, and operates under the Nasdaq Global Market with the symbol XGN[3]. Forward-Looking Statements - No forward-looking statements or specific guidance were provided in the current report[6]. - The company has not indicated any new product developments or market expansions in this report[4].